Stock Market & Financial Investment News

News Breaks January 7, 2013 08:51 EDT PPHM Peregrine upgraded to Buy from Neutral at Roth Capital Roth Capital upgraded Peregrine citing increased Bavi visibility following the Ph II NSCLC trial update. Price target raised to $2.70. News For PPHM From The Last 14 Days Check below for free stories on PPHM the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 10, 2013 12:28 EDT PPHM Peregrine management to meet with Roth Capital Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.